Clinical Trial: A Phase 1 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cystic Fibrosis
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Single Dose Escalation Study Evaluating the Safety and Tolerability of VX-522 in Subjects 18 Years of Age and Older With Cystic Fibrosis and a CFTR Genotype Not Responsive to CFTR Modulator
Brief Summary:
The purpose of this study is to evaluate the safety and tolerability of VX-522 in participants 18 years of age and older with cystic fibrosis and a cystic fibrosis transmembrane conductance regulator (CFTR) genotype not responsive to CFTR modulator therapy.
Read more